Fennec Pharmaceuticals (FENC) Other Gross PP&E Adjustments (2022 - 2025)
Fennec Pharmaceuticals posted quarterly Other Gross PP&E Adjustments of -$22000.0 for Q4 2025, up 42.11% year-on-year from -$15481.5 in Q4 2024, and up 42.11% on a QoQ basis from -$38000.0 in Q4 2024.
Fennec Pharmaceuticals (FENC) has 4 years of Other Gross PP&E Adjustments data on file, last reported at -$22000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 42.11% year-over-year to -$22000.0; the trailing twelve-month figure through Dec 2025 stood at -$22000.0 (up 42.11% YoY), and the FY2025 full-year result was -$22000.0, up 42.11% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$22000.0, up from -$38000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$22000.0 in Q4 2025 and bottomed at -$77000.0 in Q4 2022.
- The 4-year median for Other Gross PP&E Adjustments is -$38000.0 (2024), against an average of -$47800.0.
- The widest annual swing landed in 2023, when Other Gross PP&E Adjustments climbed 5.19%; it then surged 47.95% in 2024.
- A 4-year view of Other Gross PP&E Adjustments shows it stood at -$77000.0 in 2022, then gained by 5.19% to -$73000.0 in 2023, then soared by 47.95% to -$38000.0 in 2024, then surged by 42.11% to -$22000.0 in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$22000.0 (Q4 2025), -$38000.0 (Q4 2024), and -$73000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | -22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2023 | -73,000.00 |
| Dec 31, 2023 | -73,000.00 |
| Sep 30, 2023 | -29,000.00 |
| Sep 30, 2023 | -29,000.00 |
| Dec 31, 2022 | -77,000.00 |
| Dec 31, 2022 | -77,000.00 |